Advanced search
1 file | 911.70 KB

CRISPR/Cas9 disease models in zebrafish and Xenopus : the genetic renaissance of fish and frogs

Thomas Naert (UGent) and Kris Vleminckx (UGent)
Author
Organization
Abstract
The speed by which clinical genomics is currently identifying novel potentially pathogenic variants is outperforming the speed by which these can be functionally (genotype-phenotype) annotated in animal disease models. However, over the past few years the emergence of CRISPR/Cas9 as a straight-forward genome editing technology has revolutionized disease modeling in vertebrate non-mammalian model organisms such as zebrafish, medaka and Xenopus. It is now finally possible, by CRISPR/Cas9, to rapidly establish clinically relevant disease models in these organisms. Interestingly, these can provide both cost-effective genotype-phenotype correlations for gene-(variants) and genomic rearrangements obtained from clinical practice, as well as be exploited to perform translational research to improve prospects of disease afflicted patients. In this review, we show an extensive overview of these new CRISPR/Cas9-mediated disease models and provide future prospects that will allow increasingly accurate modeling of human disease in zebrafish, medaka and Xenopus.
Keywords
Biotechnology, Molecular Medicine, Drug Discovery

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 911.70 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Naert, Thomas, and Kris Vleminckx. 2018. “CRISPR/Cas9 Disease Models in Zebrafish and Xenopus : the Genetic Renaissance of Fish and Frogs.” Drug Discovery Today. Technologies 28: 41–52.
APA
Naert, T., & Vleminckx, K. (2018). CRISPR/Cas9 disease models in zebrafish and Xenopus : the genetic renaissance of fish and frogs. DRUG DISCOVERY TODAY. TECHNOLOGIES, 28, 41–52.
Vancouver
1.
Naert T, Vleminckx K. CRISPR/Cas9 disease models in zebrafish and Xenopus : the genetic renaissance of fish and frogs. DRUG DISCOVERY TODAY. TECHNOLOGIES. 2018;28:41–52.
MLA
Naert, Thomas, and Kris Vleminckx. “CRISPR/Cas9 Disease Models in Zebrafish and Xenopus : the Genetic Renaissance of Fish and Frogs.” DRUG DISCOVERY TODAY. TECHNOLOGIES 28 (2018): 41–52. Print.
@article{8586408,
  abstract     = {The speed by which clinical genomics is currently identifying novel potentially pathogenic variants is outperforming the speed by which these can be functionally (genotype-phenotype) annotated in animal disease models. However, over the past few years the emergence of CRISPR/Cas9 as a straight-forward genome editing technology has revolutionized disease modeling in vertebrate non-mammalian model organisms such as zebrafish, medaka and Xenopus. It is now finally possible, by CRISPR/Cas9, to rapidly establish clinically relevant disease models in these organisms. Interestingly, these can provide both cost-effective genotype-phenotype correlations for gene-(variants) and genomic rearrangements obtained from clinical practice, as well as be exploited to perform translational research to improve prospects of disease afflicted patients. In this review, we show an extensive overview of these new CRISPR/Cas9-mediated disease models and provide future prospects that will allow increasingly accurate modeling of human disease in zebrafish, medaka and Xenopus.},
  author       = {Naert, Thomas and Vleminckx, Kris},
  issn         = {1740-6749},
  journal      = {DRUG DISCOVERY TODAY. TECHNOLOGIES},
  language     = {eng},
  pages        = {41--52},
  title        = {CRISPR/Cas9 disease models in zebrafish and Xenopus : the genetic renaissance of fish and frogs},
  url          = {http://dx.doi.org/10.1016/j.ddtec.2018.07.001},
  volume       = {28},
  year         = {2018},
}

Altmetric
View in Altmetric